Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells

Raktima Datta, Sunil Krishna Halder, Binhao Zhang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose: Curcumin has been shown to have potent anticancer activities like inhibition of cell proliferation, induction of apoptosis, and suppression of angiogenesis. Transforming growth factor-β (TGF-β) signaling plays a complex role in tumor suppression and promotion depending on the tumor type and stage. However, the effect of curcumin on TGF-β signaling in cancer cells and the role of TGF-β signaling in curcumin-induced anticancer activities have not been determined. Here, we investigate the role of curcumin on TGF-β signaling, and whether TGF-β signaling is involved in the antitumor activities of curcumin. Methods: Human non-small cell lung cancer (NSCLC) cell lines, ACC-LC-176 (without TGF-β signaling), H358, and A549 (with TGF-β signaling) were treated with curcumin to determine cell growth, apoptosis, and tumorigenicity. Antitumor activities of curcumin were determined using these cell lines and an in vivo mouse model. We also tested the effect of curcumin on TGF-β/Smad signaling by western blotting and by luciferase assays. Results: Curcumin inhibited cell growth and induced apoptosis of all three NSCLC cell lines in vitro and in vivo. It significantly reduced subcutaneous tumor growth by these three cell lines irrespective of TGF-β signaling status. Curcumin inhibited TGF-β-induced Smad2/3 phosphorylation and transcription in H358 and A549 cells, but not in ACC-LC-176 cells. Conclusions: Curcumin reduces tumorigenicity of human lung cancer cells in vitro and in vivo by inhibiting cell proliferation and promoting apoptosis. These results suggest that TGF-β signaling is not directly involved in curcumin-mediated growth inhibition, induction of apoptosis, and inhibition of tumorigenicity.

Original languageEnglish (US)
Pages (from-to)563-572
Number of pages10
JournalJournal of Cancer Research and Clinical Oncology
Volume139
Issue number4
DOIs
StatePublished - Apr 1 2013

Fingerprint

Curcumin
Transforming Growth Factors
Lung Neoplasms
Apoptosis
Cell Line
Growth
Non-Small Cell Lung Carcinoma
Neoplasms
Cell Proliferation
Luciferases
Western Blotting
Phosphorylation

Keywords

  • Apoptosis
  • Curcumin
  • NSCLC
  • Smad
  • TGF-β
  • Tumorigenicity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells. / Datta, Raktima; Halder, Sunil Krishna; Zhang, Binhao.

In: Journal of Cancer Research and Clinical Oncology, Vol. 139, No. 4, 01.04.2013, p. 563-572.

Research output: Contribution to journalArticle

Datta, Raktima ; Halder, Sunil Krishna ; Zhang, Binhao. / Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells. In: Journal of Cancer Research and Clinical Oncology. 2013 ; Vol. 139, No. 4. pp. 563-572.
@article{523cfff00fac43c5962ba40654fedc65,
title = "Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells",
abstract = "Purpose: Curcumin has been shown to have potent anticancer activities like inhibition of cell proliferation, induction of apoptosis, and suppression of angiogenesis. Transforming growth factor-β (TGF-β) signaling plays a complex role in tumor suppression and promotion depending on the tumor type and stage. However, the effect of curcumin on TGF-β signaling in cancer cells and the role of TGF-β signaling in curcumin-induced anticancer activities have not been determined. Here, we investigate the role of curcumin on TGF-β signaling, and whether TGF-β signaling is involved in the antitumor activities of curcumin. Methods: Human non-small cell lung cancer (NSCLC) cell lines, ACC-LC-176 (without TGF-β signaling), H358, and A549 (with TGF-β signaling) were treated with curcumin to determine cell growth, apoptosis, and tumorigenicity. Antitumor activities of curcumin were determined using these cell lines and an in vivo mouse model. We also tested the effect of curcumin on TGF-β/Smad signaling by western blotting and by luciferase assays. Results: Curcumin inhibited cell growth and induced apoptosis of all three NSCLC cell lines in vitro and in vivo. It significantly reduced subcutaneous tumor growth by these three cell lines irrespective of TGF-β signaling status. Curcumin inhibited TGF-β-induced Smad2/3 phosphorylation and transcription in H358 and A549 cells, but not in ACC-LC-176 cells. Conclusions: Curcumin reduces tumorigenicity of human lung cancer cells in vitro and in vivo by inhibiting cell proliferation and promoting apoptosis. These results suggest that TGF-β signaling is not directly involved in curcumin-mediated growth inhibition, induction of apoptosis, and inhibition of tumorigenicity.",
keywords = "Apoptosis, Curcumin, NSCLC, Smad, TGF-β, Tumorigenicity",
author = "Raktima Datta and Halder, {Sunil Krishna} and Binhao Zhang",
year = "2013",
month = "4",
day = "1",
doi = "10.1007/s00432-012-1352-6",
language = "English (US)",
volume = "139",
pages = "563--572",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells

AU - Datta, Raktima

AU - Halder, Sunil Krishna

AU - Zhang, Binhao

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Purpose: Curcumin has been shown to have potent anticancer activities like inhibition of cell proliferation, induction of apoptosis, and suppression of angiogenesis. Transforming growth factor-β (TGF-β) signaling plays a complex role in tumor suppression and promotion depending on the tumor type and stage. However, the effect of curcumin on TGF-β signaling in cancer cells and the role of TGF-β signaling in curcumin-induced anticancer activities have not been determined. Here, we investigate the role of curcumin on TGF-β signaling, and whether TGF-β signaling is involved in the antitumor activities of curcumin. Methods: Human non-small cell lung cancer (NSCLC) cell lines, ACC-LC-176 (without TGF-β signaling), H358, and A549 (with TGF-β signaling) were treated with curcumin to determine cell growth, apoptosis, and tumorigenicity. Antitumor activities of curcumin were determined using these cell lines and an in vivo mouse model. We also tested the effect of curcumin on TGF-β/Smad signaling by western blotting and by luciferase assays. Results: Curcumin inhibited cell growth and induced apoptosis of all three NSCLC cell lines in vitro and in vivo. It significantly reduced subcutaneous tumor growth by these three cell lines irrespective of TGF-β signaling status. Curcumin inhibited TGF-β-induced Smad2/3 phosphorylation and transcription in H358 and A549 cells, but not in ACC-LC-176 cells. Conclusions: Curcumin reduces tumorigenicity of human lung cancer cells in vitro and in vivo by inhibiting cell proliferation and promoting apoptosis. These results suggest that TGF-β signaling is not directly involved in curcumin-mediated growth inhibition, induction of apoptosis, and inhibition of tumorigenicity.

AB - Purpose: Curcumin has been shown to have potent anticancer activities like inhibition of cell proliferation, induction of apoptosis, and suppression of angiogenesis. Transforming growth factor-β (TGF-β) signaling plays a complex role in tumor suppression and promotion depending on the tumor type and stage. However, the effect of curcumin on TGF-β signaling in cancer cells and the role of TGF-β signaling in curcumin-induced anticancer activities have not been determined. Here, we investigate the role of curcumin on TGF-β signaling, and whether TGF-β signaling is involved in the antitumor activities of curcumin. Methods: Human non-small cell lung cancer (NSCLC) cell lines, ACC-LC-176 (without TGF-β signaling), H358, and A549 (with TGF-β signaling) were treated with curcumin to determine cell growth, apoptosis, and tumorigenicity. Antitumor activities of curcumin were determined using these cell lines and an in vivo mouse model. We also tested the effect of curcumin on TGF-β/Smad signaling by western blotting and by luciferase assays. Results: Curcumin inhibited cell growth and induced apoptosis of all three NSCLC cell lines in vitro and in vivo. It significantly reduced subcutaneous tumor growth by these three cell lines irrespective of TGF-β signaling status. Curcumin inhibited TGF-β-induced Smad2/3 phosphorylation and transcription in H358 and A549 cells, but not in ACC-LC-176 cells. Conclusions: Curcumin reduces tumorigenicity of human lung cancer cells in vitro and in vivo by inhibiting cell proliferation and promoting apoptosis. These results suggest that TGF-β signaling is not directly involved in curcumin-mediated growth inhibition, induction of apoptosis, and inhibition of tumorigenicity.

KW - Apoptosis

KW - Curcumin

KW - NSCLC

KW - Smad

KW - TGF-β

KW - Tumorigenicity

UR - http://www.scopus.com/inward/record.url?scp=84876418228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876418228&partnerID=8YFLogxK

U2 - 10.1007/s00432-012-1352-6

DO - 10.1007/s00432-012-1352-6

M3 - Article

C2 - 23224523

AN - SCOPUS:84876418228

VL - 139

SP - 563

EP - 572

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 4

ER -